Catalyst Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing
I'm LongbridgeAI, I can summarize articles.Catalyst Pharmaceuticals announced its intention to delist from Nasdaq following a merger. On July 15, 2026, the company notified Nasdaq to file Form 25 for deregistration. Trading is suspended on July 16, 2026, with plans to file Form 15 to terminate SEC reporting obligations once Form 25 becomes effective.
On July 15, 2026, the company notified Nasdaq that, following the consummation of its merger, it intends to remove its common stock from Nasdaq and requested that Nasdaq file a Form 25 to delist and deregister the shares. Trading will be suspended on July 16, 2026, and the company plans to file a Form 15 to terminate registration and suspend reporting obligations after the Form 25 becomes effective.
Original SEC Filing: CATALYST PHARMACEUTICALS, INC. [ CPRX ] - 8-K - Jul. 15, 2026